LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

Putative cyclophilin 15

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
Putative cyclophilin 15
Gene product:
cyclophilin 15, putative
Species:
Leishmania major
UniProt:
Q4QCV2_LEIMA
TriTrypDb:
LmjF.20.0940 * , LMJLV39_200014800 * , LMJSD75_200014600
Length:
462

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 11
NetGPI no yes: 0, no: 11
Could not find GO cellular_component term for this entry.

Expansion

Sequence features

Q4QCV2
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: Q4QCV2

Function

Biological processes
Term Name Level Count
GO:0000413 protein peptidyl-prolyl isomerization 7 12
GO:0006807 nitrogen compound metabolic process 2 12
GO:0008152 metabolic process 1 12
GO:0018193 peptidyl-amino acid modification 5 12
GO:0018208 peptidyl-proline modification 6 12
GO:0019538 protein metabolic process 3 12
GO:0036211 protein modification process 4 12
GO:0043170 macromolecule metabolic process 3 12
GO:0043412 macromolecule modification 4 12
GO:0044238 primary metabolic process 2 12
GO:0071704 organic substance metabolic process 2 12
GO:1901564 organonitrogen compound metabolic process 3 12
Molecular functions
Term Name Level Count
GO:0003755 peptidyl-prolyl cis-trans isomerase activity 3 12
GO:0003824 catalytic activity 1 12
GO:0016853 isomerase activity 2 12
GO:0016859 cis-trans isomerase activity 3 12
GO:0140096 catalytic activity, acting on a protein 2 12

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 264 268 PF00656 0.674
CLV_NRD_NRD_1 286 288 PF00675 0.715
CLV_NRD_NRD_1 300 302 PF00675 0.702
CLV_NRD_NRD_1 346 348 PF00675 0.686
CLV_NRD_NRD_1 407 409 PF00675 0.503
CLV_NRD_NRD_1 411 413 PF00675 0.490
CLV_NRD_NRD_1 417 419 PF00675 0.510
CLV_PCSK_FUR_1 283 287 PF00082 0.748
CLV_PCSK_KEX2_1 212 214 PF00082 0.544
CLV_PCSK_KEX2_1 285 287 PF00082 0.700
CLV_PCSK_KEX2_1 300 302 PF00082 0.707
CLV_PCSK_KEX2_1 344 346 PF00082 0.606
CLV_PCSK_KEX2_1 411 413 PF00082 0.486
CLV_PCSK_KEX2_1 417 419 PF00082 0.532
CLV_PCSK_KEX2_1 460 462 PF00082 0.631
CLV_PCSK_PC1ET2_1 212 214 PF00082 0.450
CLV_PCSK_PC1ET2_1 344 346 PF00082 0.566
CLV_PCSK_PC1ET2_1 460 462 PF00082 0.779
CLV_PCSK_SKI1_1 127 131 PF00082 0.382
CLV_PCSK_SKI1_1 300 304 PF00082 0.564
CLV_PCSK_SKI1_1 412 416 PF00082 0.556
DEG_APCC_DBOX_1 15 23 PF00400 0.585
DEG_SCF_FBW7_1 14 21 PF00400 0.464
DEG_SPOP_SBC_1 421 425 PF00917 0.598
DOC_CKS1_1 186 191 PF01111 0.462
DOC_CKS1_1 91 96 PF01111 0.493
DOC_CYCLIN_yCln2_LP_2 72 78 PF00134 0.404
DOC_MAPK_FxFP_2 36 39 PF00069 0.321
DOC_MAPK_gen_1 112 121 PF00069 0.343
DOC_MAPK_gen_1 57 66 PF00069 0.382
DOC_PP2B_LxvP_1 169 172 PF13499 0.541
DOC_PP2B_LxvP_1 4 7 PF13499 0.481
DOC_PP2B_LxvP_1 72 75 PF13499 0.491
DOC_PP4_FxxP_1 36 39 PF00568 0.321
DOC_PP4_FxxP_1 49 52 PF00568 0.372
DOC_USP7_MATH_1 154 158 PF00917 0.553
DOC_USP7_MATH_1 251 255 PF00917 0.655
DOC_USP7_MATH_1 316 320 PF00917 0.719
DOC_USP7_MATH_1 339 343 PF00917 0.763
DOC_USP7_MATH_1 419 423 PF00917 0.590
DOC_USP7_MATH_1 52 56 PF00917 0.533
DOC_USP7_MATH_2 75 81 PF00917 0.367
DOC_USP7_UBL2_3 451 455 PF12436 0.646
DOC_USP7_UBL2_3 456 460 PF12436 0.586
DOC_WW_Pin1_4 14 19 PF00397 0.516
DOC_WW_Pin1_4 185 190 PF00397 0.550
DOC_WW_Pin1_4 6 11 PF00397 0.551
DOC_WW_Pin1_4 90 95 PF00397 0.523
LIG_14-3-3_CanoR_1 138 142 PF00244 0.532
LIG_14-3-3_CanoR_1 213 222 PF00244 0.518
LIG_14-3-3_CanoR_1 362 368 PF00244 0.678
LIG_14-3-3_CanoR_1 57 62 PF00244 0.345
LIG_Actin_WH2_2 197 214 PF00022 0.513
LIG_BRCT_BRCA1_1 318 322 PF00533 0.624
LIG_BRCT_BRCA1_1 325 329 PF00533 0.586
LIG_BRCT_BRCA1_1 34 38 PF00533 0.428
LIG_BRCT_BRCA1_2 318 324 PF00533 0.652
LIG_BRCT_BRCA1_2 325 331 PF00533 0.612
LIG_FHA_1 124 130 PF00498 0.379
LIG_FHA_1 19 25 PF00498 0.452
LIG_FHA_1 203 209 PF00498 0.425
LIG_FHA_1 361 367 PF00498 0.588
LIG_FHA_2 185 191 PF00498 0.536
LIG_FHA_2 262 268 PF00498 0.533
LIG_FHA_2 83 89 PF00498 0.500
LIG_LIR_Apic_2 33 39 PF02991 0.315
LIG_LIR_Apic_2 48 52 PF02991 0.476
LIG_LIR_Apic_2 88 94 PF02991 0.477
LIG_LIR_Gen_1 177 186 PF02991 0.361
LIG_LIR_Gen_1 379 386 PF02991 0.508
LIG_LIR_Nem_3 128 133 PF02991 0.335
LIG_LIR_Nem_3 163 169 PF02991 0.431
LIG_LIR_Nem_3 177 183 PF02991 0.323
LIG_LIR_Nem_3 194 198 PF02991 0.477
LIG_LIR_Nem_3 241 245 PF02991 0.487
LIG_LIR_Nem_3 319 325 PF02991 0.516
LIG_LIR_Nem_3 379 384 PF02991 0.522
LIG_LIR_Nem_3 48 53 PF02991 0.490
LIG_MLH1_MIPbox_1 319 323 PF16413 0.615
LIG_PTB_Apo_2 60 67 PF02174 0.299
LIG_REV1ctd_RIR_1 320 328 PF16727 0.567
LIG_REV1ctd_RIR_1 381 389 PF16727 0.616
LIG_SH2_CRK 166 170 PF00017 0.503
LIG_SH2_CRK 242 246 PF00017 0.409
LIG_SH2_CRK 91 95 PF00017 0.490
LIG_SH2_NCK_1 91 95 PF00017 0.487
LIG_SH2_PTP2 180 183 PF00017 0.368
LIG_SH2_STAT5 180 183 PF00017 0.368
LIG_SH2_STAT5 242 245 PF00017 0.547
LIG_SH3_1 270 276 PF00018 0.617
LIG_SH3_3 136 142 PF00018 0.388
LIG_SH3_3 183 189 PF00018 0.483
LIG_SH3_3 21 27 PF00018 0.447
LIG_SH3_3 270 276 PF00018 0.711
LIG_SH3_3 4 10 PF00018 0.516
LIG_TYR_ITIM 164 169 PF00017 0.481
LIG_TYR_ITIM 240 245 PF00017 0.477
MOD_CDK_SPxxK_3 185 192 PF00069 0.403
MOD_CK1_1 123 129 PF00069 0.363
MOD_CK1_1 246 252 PF00069 0.661
MOD_CK1_1 422 428 PF00069 0.666
MOD_CK1_1 436 442 PF00069 0.551
MOD_CK2_1 114 120 PF00069 0.481
MOD_CK2_1 184 190 PF00069 0.485
MOD_CK2_1 244 250 PF00069 0.451
MOD_CK2_1 82 88 PF00069 0.478
MOD_GlcNHglycan 107 110 PF01048 0.374
MOD_GlcNHglycan 233 236 PF01048 0.340
MOD_GlcNHglycan 250 254 PF01048 0.668
MOD_GlcNHglycan 319 322 PF01048 0.618
MOD_GlcNHglycan 325 328 PF01048 0.568
MOD_GlcNHglycan 336 339 PF01048 0.620
MOD_GlcNHglycan 425 428 PF01048 0.626
MOD_GlcNHglycan 438 441 PF01048 0.733
MOD_GlcNHglycan 445 448 PF01048 0.733
MOD_GlcNHglycan 68 71 PF01048 0.479
MOD_GlcNHglycan 79 82 PF01048 0.395
MOD_GSK3_1 121 128 PF00069 0.351
MOD_GSK3_1 14 21 PF00069 0.611
MOD_GSK3_1 148 155 PF00069 0.547
MOD_GSK3_1 240 247 PF00069 0.520
MOD_GSK3_1 249 256 PF00069 0.649
MOD_GSK3_1 357 364 PF00069 0.628
MOD_GSK3_1 419 426 PF00069 0.690
MOD_GSK3_1 429 436 PF00069 0.606
MOD_GSK3_1 443 450 PF00069 0.619
MOD_N-GLC_1 307 312 PF02516 0.661
MOD_NEK2_1 105 110 PF00069 0.343
MOD_NEK2_1 240 245 PF00069 0.529
MOD_NEK2_1 317 322 PF00069 0.571
MOD_NEK2_1 323 328 PF00069 0.496
MOD_NEK2_1 361 366 PF00069 0.623
MOD_NEK2_1 449 454 PF00069 0.742
MOD_NEK2_1 66 71 PF00069 0.382
MOD_PIKK_1 171 177 PF00454 0.484
MOD_PIKK_1 213 219 PF00454 0.572
MOD_PIKK_1 429 435 PF00454 0.757
MOD_PIKK_1 52 58 PF00454 0.367
MOD_PK_1 148 154 PF00069 0.568
MOD_PKA_2 137 143 PF00069 0.544
MOD_PKA_2 271 277 PF00069 0.739
MOD_PKA_2 361 367 PF00069 0.580
MOD_Plk_1 240 246 PF00069 0.434
MOD_Plk_1 32 38 PF00069 0.419
MOD_Plk_2-3 114 120 PF00069 0.481
MOD_Plk_4 114 120 PF00069 0.423
MOD_Plk_4 125 131 PF00069 0.262
MOD_Plk_4 160 166 PF00069 0.363
MOD_Plk_4 240 246 PF00069 0.353
MOD_Plk_4 32 38 PF00069 0.444
MOD_Plk_4 45 51 PF00069 0.461
MOD_ProDKin_1 14 20 PF00069 0.515
MOD_ProDKin_1 185 191 PF00069 0.549
MOD_ProDKin_1 6 12 PF00069 0.549
MOD_ProDKin_1 90 96 PF00069 0.522
MOD_SUMO_rev_2 288 297 PF00179 0.533
TRG_ENDOCYTIC_2 166 169 PF00928 0.424
TRG_ENDOCYTIC_2 179 182 PF00928 0.280
TRG_ENDOCYTIC_2 242 245 PF00928 0.488
TRG_ER_diArg_1 283 286 PF00400 0.630
TRG_ER_diArg_1 299 301 PF00400 0.663
TRG_ER_diArg_1 345 347 PF00400 0.720
TRG_ER_diArg_1 411 413 PF00400 0.538
TRG_ER_diLys_1 458 462 PF00400 0.528
TRG_NLS_Bipartite_1 212 232 PF00514 0.459
TRG_NLS_MonoCore_2 343 348 PF00514 0.623
TRG_NLS_MonoExtC_3 343 349 PF00514 0.560
TRG_NLS_MonoExtC_3 407 412 PF00514 0.574
TRG_NLS_MonoExtC_3 454 459 PF00514 0.724
TRG_NLS_MonoExtN_4 227 232 PF00514 0.446
TRG_NLS_MonoExtN_4 341 348 PF00514 0.596
TRG_NLS_MonoExtN_4 405 412 PF00514 0.502
TRG_Pf-PMV_PEXEL_1 301 306 PF00026 0.542

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1PC45 Leptomonas seymouri 60% 100%
A0A0S4KRJ3 Bodo saltans 32% 100%
A0A1X0NWC9 Trypanosomatidae 33% 100%
A0A3S7WVY2 Leishmania donovani 90% 100%
A0A422NPI7 Trypanosoma rangeli 37% 100%
A4HYT6 Leishmania infantum 88% 100%
C9ZIB2 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 36% 100%
E9AIE5 Leishmania braziliensis 77% 100%
E9AUN2 Leishmania mexicana (strain MHOM/GT/2001/U1103) 87% 100%
V5DRZ7 Trypanosoma cruzi 38% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS